This node is now inactive. (Merged with the Northern New England Node to form the New England Consortium Node in 2010)
The New England Node comprises five core CTPs and seven additional CTPs. These CTPs were selected on the basis of the size, breadth, and diversity of the populations they serve; volume and administrative efficiency, and commitment to evidence based treatments. The total number of unduplicated annual admission to substance use treatment is over 27,000. A wide array of treatment modalities is offered including: programs for HIV/HCV, treatment of adolescents, substance use and primary care, and psychiatric co-morbidity
- Achieving Cannabis Cessation: Evaluating N-Acetylcysteine Treatment (ACCENT) (CTN-0053)
- Starting Treatment with Agonist Replacement Therapies (START) Study (CTN-0027)
- Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment (CTN-0019)
- Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment (CTN-0018)
- Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics (CTN-0006)
- MET (Motivational Enhancement Treatment) To Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse (CTN-0004)
- Suboxone® (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules (CTN-0003)
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.
Formed with SAMHSA to reduce the gap between research results and treatment.